Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient clomipramine, ATC N06AA04, for the period 01.12.2026 - 30.11.2028 (plus extension option of 1x12 months)
Tender Summary
The DAK-Gesundheit in Germany from Europe region has released this tender for Section 130a, paragraph 8 of the German Social Code, Book V (SGB V) allows health insurance funds and pharmaceutical companies to conclude framework discount agreements for medicinal products dispensed at the expense of statutory health insurance funds. In accordance with the relevant legal provisions for the awarding of public contracts, DAK-Gesundheit conducts a regular process of active ingredient-specific, formal tendering procedures according to the regulations of Part 4 of the German Act Against Restraints of Competition (GWB). For medicinal products containing the aforementioned active ingredient clomipramine, ATC N06AA04, which the bidder is to specify in more detail in Annex 2 to the contract, DAK-Gesundheit intends to conclude drug discount agreements with as many interested pharmaceutical companies as possible before new drug discount agreements come into force. A discount agreement within the framework of the approval model for the aforementioned active ingredient will first come into force on December 1, 2026, and end on November 30, 2028 (plus an extension option of 12 months). It will also automatically terminate upon the entry into force of the exclusive agreement. with tender notice no. 712872-2026 published on 15 Oct 2026. The tender is due to expire on 05 Oct 2029. This tender is sourced from TED Europa and is eligible for suppliers interested in General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, Various medicinal products, Beta-blocking agents, Systemic hormonal preparations, excl. sex hormones. Interested bidders can obtain further information including complete bid documents or ways to participate by registering on Tender Impulse and referencing via Tender Impulse ID 15552939.
Tender Details
Tender NoticeTI Ref: 15552939
Tender Notice No
712872-2026
Tender Organisation
DAK-Gesundheit
Tender Sector
Tender Service
Worldwide
Tender Region
Tender Project Location
Tender CPV
33650000 : General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents33690000 : Various medicinal products33622600 : Beta-blocking agents33642000 : Systemic hormonal preparations, excl. sex hormones
Tender Source
TED Europa
Estimated Budget
1
Tender Document Type
Competition
Tender Deadline
05 Oct 2029 1085 days left
Tender Description
Section 130a, paragraph 8 of the German Social Code, Book V (SGB V) allows health insurance funds and pharmaceutical companies to conclude framework discount agreements for medicinal products dispensed at the expense of statutory health insurance funds. In accordance with the relevant legal provisions for the awarding of public contracts, DAK-Gesundheit conducts a regular process of active ingredient-specific, formal tendering procedures according to the regulations of Part 4 of the German Act Against Restraints of Competition (GWB). For medicinal products containing the aforementioned active ingredient clomipramine, ATC N06AA04, which the bidder is to specify in more detail in Annex 2 to the contract, DAK-Gesundheit intends to conclude drug discount agreements with as many interested pharmaceutical companies as possible before new drug discount agreements come into force. A discount agreement within the framework of the approval model for the aforementioned active ingredient will first come into force on December 1, 2026, and end on November 30, 2028 (plus an extension option of 12 months). It will also automatically terminate upon the entry into force of the exclusive agreement.
Tender Bidding Type
Tender Document
Unlock Full Details — Register Free
Already have an account? Log in to download the tender document.
Frequently Asked Questions About This Tender
Who has issued this tender, and what is it for?
The tender has been issued by DAK-Gesundheit in Germany. Such a type of tender falls under General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, Various medicinal products, Beta-blocking agents, Systemic hormonal preparations, excl. sex hormones, within the Oil and Gas sector, and is listed on Tender Impulse under notice number 712872-2026.
What are the key dates for this tender?
The notice was published on 15 Oct 2026 and submissions close on 05 Oct 2029. Late bids are rarely accepted in public procurement, so aim to have your documents ready several days before the closing date.
Which CPV codes apply to this tender?
It is classified under CPV codes 33650000, 33690000, 33622600, 33642000, which correspond to General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, Various medicinal products, Beta-blocking agents, Systemic hormonal preparations, excl. sex hormones. If your company supplies these products or services, these are the codes to save in your alert profile so no matching tender passes you by.
Can I submit my bid for this tender to Tender Impulse?
No - and this matters. Tender Impulse is a tender aggregation and alert service: we collect procurement notices from official sources around the world and list them in one place. We do not receive, forward or evaluate bids. Your bid for this tender must be submitted directly to DAK-Gesundheit, using the method described in the original tender document, before 05 Oct 2029. Tender Impulse provides complete assistance in submitting all bids posted on its website.
How do I get the bid documents and participation details?
Request a live demo on Tender Impulse and our tender experts will walk you through this listing, share the available documents, and explain how to submit your bid to DAK-Gesundheit. Subscribers also receive help with registration requirements and, where needed, translation of non-English notices - but the submission itself always goes from you to the buyer.
How can I find more tenders like this in Germany?
There are currently 30003 live tenders of 564836 total tenders from Germany on Tender Impulse. You can browse them on our Germany tenders page, or save a search combining Germany with CPV codes 33650000, 33690000, 33622600, 33642000 - we will then email you every new match on the day it is published.
How to prepare for this bid?
Suppliers must verify technical specifications, the delivery schedules and any other intrinsic details as provided in the complete bid documents before deciding to submit their bids. All necessary certifications and supplier registrations must be undertaken before participation.
Is this tender beneficial for me?
The procurement is applicable to companies in the General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, Various medicinal products, Beta-blocking agents, Systemic hormonal preparations, excl. sex hormones and related industries. If you belong to this industry, you can review the technical documents before assessing your relevance to your company.
What is the procurement trend for Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient clomipramine, ATC N06AA04, for the period 01.12.2026 - 30.11.2028 (plus extension option of 1x12 months)?
The public procurement trends for Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient clomipramine, ATC N06AA04, for the period 01.12.2026 - 30.11.2028 (plus extension option of 1x12 months) can be assessed by viewing historical data and buying patterns for this product. Subscribed members can view and even download reports of tenders released in the past for their market research. This shall allow them to carefully prepare a compelling bid.
Explore More General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, Various medicinal products, Beta-blocking agents, Systemic hormonal preparations, excl. sex hormones Tenders in Germany, Europe Region and Worldwide
Looking for more tenders like this one in General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, Various medicinal products, Beta-blocking agents, Systemic hormonal preparations, excl. sex hormones? With millions of global procurement opportunities and new tenders added daily, Tender Impulse is your gateway to international and local contracting success. Whether you're targeting the Oil and Gas sector in Germany, or expanding across regions, we provide live, accurate and relevant updates every day.
Our platform sources tenders from national and local government portals, international development and funding agencies, municipal corporations, state authorities, NGOs, education ministries and public-private partnerships.
Daily Tender Updates Across 190+ Countries
Every day we add hundreds of new RFPs, RFQs, EOIs and contract awards across multiple sectors and geographies. This tender from Germany is just a sample of what's available right now - there are currently 30,003 live Germany tenders to explore.
Search Smarter with CPV and Industry Matching
Each listing is categorised using CPV codes such as 33650000, 33690000, 33622600, 33642000, enabling precise filtering by tender type, location, industry, deadline and issuing organisation.
Start Your Tender Journey
Request a free live demo to unlock tenders customised to your sector, country and CPV categories - with alerts, documents and submission support.
